(3-S)-3-[((3-AMINO-3-CARBOXY)-PROPYL)-(HYDROXY)-PHOSPHINYL]-2-(PHOSPHONOMETHYL)-PROPANOIC_ACID;LSP1-2029
Compound with spectra: 1 NMR
![(3-S)-3-[((3-AMINO-3-CARBOXY)-PROPYL)-(HYDROXY)-PHOSPHINYL]-2-(PHOSPHONOMETHYL)-PROPANOIC_ACID;LSP1-2029](/api/compound/EEKGKiYwkLO.png?ph=true&h=300&w=458 "(3-S)-3-[((3-AMINO-3-CARBOXY)-PROPYL)-(HYDROXY)-PHOSPHINYL]-2-(PHOSPHONOMETHYL)-PROPANOIC_ACID;LSP1-2029")
| SpectraBase Compound ID | EEKGKiYwkLO |
|---|---|
| InChI | InChI=1S/C8H17NO9P2/c9-6(8(12)13)1-2-19(14,15)5(3-7(10)11)4-20(16,17)18/h5-6H,1-4,9H2,(H,10,11)(H,12,13)(H,14,15)(H2,16,17,18)/t5?,6-/m0/s1 |
| InChIKey | OTYXWVKEWNCHHC-GDVGLLTNSA-N |
| Mol Weight | 333.17 g/mol |
| Molecular Formula | C8H17NO9P2 |
| Exact Mass | 333.037855 g/mol |
| Enantiomer InChIKey | OTYXWVKEWNCHHC-PRJDIBJQSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-PROPANOATE
ETHYL_2-[(2-BROMOETHYL-(HYDROXY)-PHOSPHINYL)-METHYL]-BUTAN-1,4-DIOATE
ERYTHRO-METHYL 4-(METHYLMETHOXYPHOSPHORYL)-2-METHYL-2-PARA-BROMOBENZYLIDENAMINOBUTANOATE (Z/E MIXTURE)
(2R)-2-[3-[(1-ACETYLAMINO-5-AMINOPENTYL)-(HYDROXY)-PHOSPHONYL]-PROPIONYLAMINO]-PROPIONIC-ACID
3-(acetylamino)phenyl 2-methyl-3-furoate
ERYTHRO-METHYL 4-(METHYLMETHOXYPHOSPHORYL)-2-METHYL-2-BENZYLIDENAMINOBUTANOATE (Z/E MIXTURE)
APPXQTVAAMWLOM-UHFFFAOYSA-N
2,6-ANHYDRO-1,7-DIDEOXY-L-GLYCERO-L-TALO-HEPTIT-1-YL-PHOSPHONIC-ACID
Pyrrolo[1,2-c][1,3]oxazol-1-one, perhydro-3-(trichloromethyl)
ETHYL-(2R,3S)-2-AMINO-3-BENZYLOXYMETHYL-4-(DIETHOXYPHOSPHORYL)-BUTANOATE
| Title | Journal or Book | Year |
|---|---|---|
| A Virtual Screening Hit Reveals New Possibilities for Developing Group III Metabotropic Glutamate Receptor Agonists | Journal of Medicinal Chemistry | 2010 |